All lobbying filings

Capitol Counsel LLC

Capitol Counsel LLC filed a Q3 report for Pharmaceutical Research and Manufacturers of America (PHRMA) on October 19, 2025, reporting $50,000 in lobbying income.

Lobbying for Pharmaceutical Research and Manufacturers of America (PHRMA) · Represents pharmaceutical research and biotechnology companies

As filed: CAPITOL COUNSEL LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA).

All filings by Capitol Counsel LLC · Everything Pharmaceutical Research and Manufacturers of America (PHRMA) has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 19, 2025

Income

$50,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Legislative issues related to Medicare Part B prescription drug reimbursement. Pharmacy Benefit Management Reform in Medicare Part D, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.

Health Issues

Monitor implementation of the 340B Prescription Drug Discount Program and implementation of the Inflation Reduction Act of 2022 (P.L. No: 117-169). Issues regarding FDA user fee programs. Pharmacy Benefit Management Reform. Public health issues impacting patient access to treatments.

Bills named in this filing 1

H.R. 1
One Big Beautiful Bill Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.